These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 347137)

  • 1. [Use of ethaphenone for the treatment of ischemic heart disease].
    Savenkov PM; Shcherbatkin DD; Grudtsyn GV; Katashchuk GI; Tarnuev VA
    Kardiologiia; 1978 Mar; 18(3):43-7. PubMed ID: 347137
    [No Abstract]   [Full Text] [Related]  

  • 2. [General aspects of a project of a controlled clinical experimentation with coronary-active drug, evaluated on the base of the onset of remission of signs and symptoms].
    Rocchi P; Cavrini P
    Boll Chim Farm; 1972 Sep; 111(9):579-82. PubMed ID: 4565804
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxyfedrine and cardiac inotropism in coronary artery disease.
    Krishnaswami S; Sathyamurthy I; Mao R; Padmakumar P
    Indian Heart J; 1984; 36(3):161-5. PubMed ID: 6490047
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controlled clinical study of large doses of etaphenone in coronary insufficiency].
    Del Guerico R
    Clin Ter; 1975 Aug; 74(4):337-63. PubMed ID: 1227752
    [No Abstract]   [Full Text] [Related]  

  • 5. [Positive inotropic effect of coronary-active drug: oxyfedrine].
    Conti G; Moreschini G; Pelosi M
    Minerva Cardioangiol; 1980 Sep; 28(9):645-7. PubMed ID: 7465070
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oxyphedrine in the treatment of coronary insufficiency: clinical evaluation].
    França HH; Martins L
    Arq Bras Cardiol; 1971 Apr; 24(2):23-30. PubMed ID: 5162299
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immediate action of oxyphedrin as evaluated using the exertion test in coronary patients].
    Velasco Rami JA; Tormo Alfonso V; Roda Nicolas J; Serra Sister E
    Rev Esp Cardiol; 1977; 30(1):17-21. PubMed ID: 854620
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug-support of active therapy for rehabilitation in coronary insufficiency].
    Schleusing G
    Z Gesamte Inn Med; 1970 Aug; 25(15):680-5. PubMed ID: 5005761
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of oxyphedrine on hemodynamics and respiration].
    Jedlicka K; Krofta K
    Cas Lek Cesk; 1972 Dec; 111(51):1201-5. PubMed ID: 4565821
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of ildamen on the heart conduction system in ischemic heart disease patients].
    Shilov AM; Borisov VG
    Farmakol Toksikol; 1987; 50(5):34-6. PubMed ID: 2891566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Action of oxyphedrine on ventricular dynamics in ischemic cardiopathy].
    Barbosa J; Lopes AS; Lopes JS; Vergara M; Benchimol AB
    Arq Bras Cardiol; 1972 Jun; 25(3):231-9. PubMed ID: 5079398
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative studies of L- as well as DL-oxyfedrine in healthy people and patients with chronic ischemic heart diseases].
    Teichmann W; Lukesch KH; Rikirsch P; Schäbitz J; Schmidt GA; Vogel HC; Sziegoleit W; Enke H
    Z Arztl Fortbild (Jena); 1976 May; 70(10):554-9. PubMed ID: 782052
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of visken in hypertension associated with ischemic heart disease and nutritional obesity].
    Khomenko VL; Vasiuk IuA; Romashkin AV; Sivkov SI; Mel'nikov AIu; Buskin VD
    Sov Med; 1990; (3):64-7. PubMed ID: 2195673
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of beta-blocking agents and beta stimulators on the intracardiac hemodynamics and myocardial contraction in ischemic heart disease].
    At'kov OIu; Krol VA; Chumburidze VB
    Ter Arkh; 1977; 49(10):57-60. PubMed ID: 22937
    [No Abstract]   [Full Text] [Related]  

  • 15. [Propafenon in ventricular arrhythmia caused by ischemic cardiopathy. Quantitative study using the Holter system].
    de Brito FS; Pereira MH; Castro I; Maia IG
    Arq Bras Cardiol; 1979 Oct; 33(4):303-10. PubMed ID: 94993
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic action of propafenon in patients with atherosclerotic coronary disease].
    Lamounier EN; Martinez Filho EE; Herrmann JL; Guimarães RD; Portugal OP; Barcellini A
    Arq Bras Cardiol; 1979 Jul; 33(1):73-6. PubMed ID: 526178
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of Ildamen].
    Krzemińska-Pakuła M; Musiał WJ
    Pol Tyg Lek; 1979 Dec; 34(52):2053-5. PubMed ID: 396524
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of isoptin on hemodynamics in patients with hypertension and ischemic heart disease].
    Zaslavskaia RM; Budenova LA; Vilkovyskiĭ FA; Malkin LM; Olevskiĭ IKh
    Klin Med (Mosk); 1985 Aug; 63(8):33-6. PubMed ID: 3908807
    [No Abstract]   [Full Text] [Related]  

  • 19. [Short-term and long-term studies of the therapeutic effectiveness of oxyphedrin in acute myocardial infarct].
    Martinelli M; Cordioli E; Mantovani BA; D'Elia N
    Minerva Cardioangiol; 1975; 23(6-7):445-51. PubMed ID: 1143667
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of oxyfedrine on exercise performance and systolic time intervals in patients of angina pectoris.
    Puri VK; Agarwal SK; Mehrotra A; Hasan M
    Indian Heart J; 1984; 36(4):226-30. PubMed ID: 6389320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.